Deciphera Pharmaceuticals, LLC clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male…Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants

   Recruitment opened

   Deciphera Pharmaceuticals, LLC·Phase 1· NCT07744802· Registry history of NCT07744802 on ClinicalTrials.gov (opens the registry)

   Updated Sep 25, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.